The genomic revolution stands poised to transform cancer therapy and many areas of medicine. SENS Research Foundation-funded researchers outline what needs to be done to take raw results and integrate them into reliable clinical practice.
We've all heard the terminology. "Age-related disease." "The diseases of aging." "The diseases of old age." But what do we mean by them? What is the connection between aging and heart disease, or cancer, or Alzheimer's? And how is SENS Research Foundation targeting that connection to prevent and cure these diseases?
Rescue Assist, Inc., a company developing a robotic product that readily maneuvers through debris and will help rescue workers find disaster survivors, has pledged 7% of its profits to SENS Research Foundation.
Dr. Aubrey de Grey, Chief Science Officer of SENS Research Foundation, has been interviewed by Daniel Levine of The Burrill Report.
Dr. Aubrey de Grey, SENS Research Foundation’s Chief Science Officer, debated Dr. Richard Faragher, Chair of the British Society for Research on Ageing and Professor of Biological Gerontology at the University of Brighton, at Oxford’s Sheldonian Theatre on February 19. SENS Research Foundation is proud to have been a sponsor of this event, and would like to thank the Oxford University Society of Biomedical Sciences (OUSBMS) for hosting it.
Mike Kope's message welcoming visitors to our newly-revised site, relaunched in early 2013. It all centers around a new tagline: reimagine aging. Of course we are still "advancing rejuvenation biotechnologies" just as vigorously as when we carried that tagline over the last couple years.
SENS Research Foundation celebrated its progress in 2012 with a party at Evidence Studios in Los Angeles on December 20.
The University of Delaware's Socratic Club will be hosting Dr. Aubrey de Grey on Tuesday, October 2.
Your vote could mean $10,000 or more for SENS Foundation to put toward our groundbreaking research into effectively mitigating age-related disease. To vote, simply visit SENS Foundation's official Chase Community Giving page.
This month, a paper reporting results from the LysoSENS project that SENS Foundation funds at Rice University will be published in the printed edition of Biotechnology and Bioengineering. The research that produced these results was primarily performed by Dr. Jacques Mathieu, and focused on identifying enzymes that can degrade or modify 7-ketocholesterol, a root cause of atherosclerosis; such enzymes could ultimately be used as a new class of regenerative therapies to prevent and reverse heart disease.
In this series of four interviews, suitable for viewers with or without a scientific background, Dr de Grey explains the key ideas, initial results and projected outcomes of the SENS program, and explains how SENS Research Foundation operates to educate and inform the public about the conceptual and practical advantages of rejuvenation biotechnology.
The "Debate of the Ages", hosted by the Oxford University Scientific Society and featuring SENS Foundation's Chief Science Officer Dr Aubrey de Grey and Oxford's Professor Colin Blakemore, has been recorded courtesy of SENS Foundation and is now available via our YouTube channel.